The potential use of biomarkers as an adjunctive tool for staging bipolar disorder-Reference-Cited by-同舟云学术

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder

Published:2009-11 Issue:8 Volume:33 Page:1366-1371
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Kapczinski Flávio,Dias Vasco Videira,Kauer-Sant'Anna Márcia,Brietzke Elisa,Vázquez Gustavo H.,Vieta Eduard,Berk Michael

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference80 articles.

1. Serum S100B and antioxidant enzymes in bipolar patients;Andreazza;J Psychiatr Res,2007

2. DNA damage in bipolar disorder;Andreazza;Psychiatry Res,2007

3. 3-Nitrotyrosine and glutathione and glutathione antioxidant system in patients in patients in the early and late stages of bipolar disorder;Andreazza;Neurosci.,2009

4. Greater cortical gray matter density in lithium-treated patients with bipolar disorder;Bearden;Biol Psychiatry,2007

5. Neuroprogression: pathways to progressive brain changes in bipolar disorder;Berk;Int J Neuropsychopharmacol,2009

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated allostatic load is associated with poorer response to repetitive transcranial magnetic stimulation in treatment-resistant depression;Psychiatry Research;2024-10

2. The recurrence of illness (ROI) index is a key factor in major depression that indicates increasing immune-linked neurotoxicity and vulnerability to suicidal behaviors;Psychiatry Research;2024-09

3. Differentiating Stages of Bipolar and Unipolar Depression—The Possible Role of sICAM-1 and sVCAM-1;Cells;2024-07-18

4. The recurrence of illness (ROI) index is a key factor in major depression that indicates increasing immune-linked neurotoxicity and vulnerability to suicidal behaviors;2024-04-13

5. Comparing the metabolic pathways of different clinical phases of bipolar disorder through metabolomics studies;Frontiers in Psychiatry;2024-01-08